InvestorsHub Logo
Followers 0
Posts 315
Boards Moderated 0
Alias Born 10/31/2007

Re: lowman post# 8432

Wednesday, 06/25/2008 12:50:23 PM

Wednesday, June 25, 2008 12:50:23 PM

Post# of 51905
Let's see:
FDA approval then produce the drugs then sell the drugs and make money.
CSA Certification on the fuel cell, then produce the fuel cells and make money.
Just like FDA approval, ARSC can't make money with out CSA approval so I would call it an obstacle.

FDA and CSA both are an approval process and both are needed before the companys can make money so they are similar obstacles.

I do understand that FDA approval is a bigger hurdle because they are trying to protect people who consume these products.
Although faster,once Certification is started, the bottom line is protection of the users are the same.

For drugs, the approval process can take years with all of the testing effectiveness and side affects. For a company like ARSC, the process is more dependent on funding to arrive at a production model.
Even though we have had our share of BS in the last two years, if we get certification and a start in production this year, it will have been a much shorter wait than FDA approval.
One can get impatient when viewing a company under a microscope every day. Most investments don't produce over night returns. A good investor can stay up to date with ARSC by checking on news once a week or two. Less stress and the same results. That doesn't hold true for day traders or shorts. Being a penny stock, if something goes south with the company, one can't expect to minimize losses by watching it nonstop. I have a strong belief that the company will pull through and all those with stock at the time will stand to see the "Google" effect. That's a gut feeling. The current energy crisis as some call it just adds to the potential up side and "Google".